ProCE Banner Activity

Slides on Early Use of Novel Biologics in Psoriatic Arthritis: An Evolving Standard of Care

Slideset Download
Review key data on when to use interleukin inhibitors in the course of psoriatic arthritis.

Released: December 29, 2020

Expiration: December 28, 2021

Share

Faculty

Vinod Chandran

Vinod Chandran, MBBS, MD, DM, PhD

Associate Professor
Consultant Rheumatologist
Division of Rheumatology
Department of Medicine
University of Toronto
University Health Network
Toronto, Canada

Alexis Ogdie

Alexis Ogdie, MD, MSCE

Director, Penn Psoriatic Arthritis and Spondylarthritis Program
Director, Penn Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Novartis Pharmaceuticals Corporation

Faculty Disclosure

Primary Author

Vinod Chandran, MBBS, MD, DM, PhD

Associate Professor
Consultant Rheumatologist
Division of Rheumatology
Department of Medicine
University of Toronto
University Health Network
Toronto, Canada

Alexis Ogdie, MD, MSCE

Director, Penn Psoriatic Arthritis and Spondylarthritis Program
Director, Penn Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania
Philadelphia, Pennsylvania